Cargando…

Effect of inactivation mode on second-generation antipsychotic TDM under COVID-19

Detalles Bibliográficos
Autores principales:	Zhang, Yan, Ding, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498544/ http://dx.doi.org/10.1016/j.jns.2021.119925

Ejemplares similares

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Evaluation of Vancomycin TDM Strategies: Prediction and Prevention of Kidney Injuries Based on Vancomycin TDM Results
por: Kim, Byungwook, et al.
Publicado: (2023)

Evidence-based TDM for antiretroviral drugs
por: Solas, Caroline
Publicado: (2010)

TDM is dead. Long live TCI!
por: Holford, Nick, et al.
Publicado: (2020)

Therapeutic drug monitoring (TDM) of atazanavir in pregnancy
por: Else, LJ, et al.
Publicado: (2010)

Fundament and Prerequisites for the Application of an Antifungal TDM Service
por: Brüggemann, Roger J. M., et al.
Publicado: (2015)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Effectiveness of second generation antipsychotics: A systematic review of randomized trials
por: Johnsen, Erik, et al.
Publicado: (2008)

First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010)

Therapeutic Drug Monitoring (TDM) Implementation in Public Hospitals in Greece in 2003 and 2021: A Comparative Analysis of TDM Evolution over the Years
por: Voulgaridou, Gavriela, et al.
Publicado: (2023)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

TEP et TDM : un couple bien assorti
Publicado: (2005)

TDM1 Regulation Determines the Number of Meiotic Divisions
por: Cifuentes, Marta, et al.
Publicado: (2016)

Importance and Reality of TDM for Antibiotics Not Covered by Insurance in Japan
por: Ebihara, Fumiya, et al.
Publicado: (2022)

Combination treatment with second generation antipsychotics other than clozapine
por: Schmidt-Kraepelin, C.
Publicado: (2021)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
por: Oh, Jee-Eun, et al.
Publicado: (2012)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Overcoming barriers to monitoring patients taking second-generation antipsychotics
por: Peña, Anita, et al.
Publicado: (2018)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics
por: Joo, Sung Woo, et al.
Publicado: (2022)

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
por: Ramachandran, Sujith, et al.
Publicado: (2016)

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis
por: Ansell, B. R. E., et al.
Publicado: (2015)

Second-generation antipsychotics and metabolic side-effects: Canadian population-based study
por: Hirsch, Lauren, et al.
Publicado: (2018)

Current and Novel Approaches to Mitigate Cardiometabolic Adverse Effects of Second-Generation Antipsychotics
por: Skonieczna-Żydecka, Karolina, et al.
Publicado: (2020)

An extended TDM method under probabilistic interval-valued hesitant fuzzy environment for stock selection
por: Noor, Qasim, et al.
Publicado: (2021)

Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2021)

Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice
por: Soenen, Rani, et al.
Publicado: (2022)

Teetering on the Edge: Second-Degree Atrioventricular Block Following Long-Acting Second-Generation Antipsychotic
por: Harrisingh, Kamahl, et al.
Publicado: (2023)

Second-generation antipsychotic use during pregnancy and risk of congenital malformations
por: Ellfolk, Maria, et al.
Publicado: (2021)

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study
por: Bodnar, Michael, et al.
Publicado: (2016)

Blood lactate levels in patients receiving first- or second- generation antipsychotics
por: Glavina, Trpimir, et al.
Publicado: (2011)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Dysphagia with second-generation antipsychotics: A case report and review of the literature
por: Crouse, Ericka L., et al.
Publicado: (2018)

Controversies in bipolar disorder; role of second-generation antipsychotic for maintenance therapy
por: Jauhar, Sameer, et al.
Publicado: (2019)

Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics
por: Klein, Lauren, et al.
Publicado: (2017)

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics
por: Rice, Jessie, et al.
Publicado: (2020)

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain
por: Grajales, Diana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3otj7dlo6t0t0k6mrui9pjbf1d